NovoCure Ltd (NVCR) stock
NVCRNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 9/3033% below fair value
$10.73−0.41 (-3.68%)
Close on Nov 18, 2026Market cap $1.25BP/E –Yield –
NovoCure pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
NovoCure's pe ratio was 734.3× on Mar 31, 2021.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2021 | Mar 31, 2021 | 734.3× | −176.4 |
| 2020 | Dec 31, 2020 | 910.7× | – |
See a number that looks wrong?